Astal Laboratories Ltd

Ticker: ASTALLTD
Risky 48/100

☆ Add to Watchlist

Investing Reference

Price
99.20
Market Cap
106.84
Debt/Equity
0.3686
ROE %
30.131
PB
2.9677
Promoter %
19.932
Pledge %
0.000
1Y Rev Growth %
172.020
5Y Rev Growth %
217.334
NP Margin %
13.891
NP Margin 5Y Avg %
2.604

Trading Reference

1M Return %
14.868
6M Return %
18.264
1Y Return %
-5.927
% Away 52W High
6.300
% Away 52W Low
48.681
Daily Volume
48353
Investment Verdict
Hold
Score 68/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Momentum
Score 76/100 · Position size: 20%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.

AI Probability Statement

Probability Statement

Astal Laboratories Ltd is currently trading near a key support level, with the 50-day EMA indicating a potential upward trend. However, resistance levels are present that could limit upside potential. Volume trends suggest moderate investor interest, indicating a cautious outlook.
Upside Probability: 15%   |   Downside Probability: 10%

Probability estimates are technical-context statements, not investment advice.

More Options

Business Overview

Astal Laboratories Ltd is a prominent player in the Indian pharmaceutical sector, dedicated to delivering high-quality healthcare solutions. Catering primarily to healthcare professionals and patients, the company focuses on innovative formulations and reliable products. With a commitment to research and development, Astal Laboratories plays a crucial role in improving health outcomes across the nation. Its strong distribution network ensures accessibility of essential medicines, making it a trusted choice for both doctors and consumers.

  • Established leader in the Indian pharmaceutical industry
  • Focus on innovative and quality healthcare solutions
  • Strong commitment to research and development
  • Wide range of products catering to diverse health needs
  • Robust distribution network for easy accessibility
  • Trusted by healthcare professionals and patients alike

Investment Thesis

Astal Laboratories Ltd stands out due to its strong promoter credibility, robust growth in digital services, and attractive valuation compared to peers. This combination positions the company for significant upside potential in the evolving healthcare landscape.

  • Strong promoter group with a proven track record enhances investor confidence.
  • Digital services segment shows promising growth, tapping into the tech-savvy consumer base.
  • Valuation metrics indicate Astal is undervalued compared to industry peers, presenting a buying opportunity.
  • Focus on innovation and quality positions the company for long-term success.
  • Potential for strong returns as the healthcare market continues to expand.

Opportunity vs Risk

Opportunities
  • Strong growth in healthcare sector
  • Expansion into new markets
  • Innovative product pipeline
  • Strategic partnerships with key players
Risks ⚠️
  • Regulatory challenges in pharmaceuticals
  • High competition in industry
  • Dependence on a few key products
  • Market volatility affecting stock price

Peer Perspective

Astal Laboratories Ltd trades at a discount to peers like Sun Pharmaceutical and Cipla, reflecting its lower growth prospects. A sustained improvement in margins could trigger a rerating, aligning its valuation more closely with industry leaders.

Future Outlook

Astal Laboratories Ltd is well-positioned for growth, driven by its innovative product pipeline. However, successful execution and stringent cost control will be crucial to fully realize its potential in the competitive market.

AI FAQs for Retail Users

  • Q: What does Astal Laboratories Ltd do?
    A: Astal Laboratories Ltd is involved in manufacturing and marketing pharmaceutical products.
  • Q: Is Astal Laboratories Ltd a publicly traded company?
    A: Yes, Astal Laboratories Ltd is listed on Indian stock exchanges.
  • Q: What sectors does Astal Laboratories operate in?
    A: Astal Laboratories primarily operates in the pharmaceutical and healthcare sectors.
  • Q: What should I consider before investing in Astal Laboratories?
    A: Consider the company's financial health, market position, and industry trends.
  • Q: How can I buy shares of Astal Laboratories?
    A: You can buy shares through a registered stockbroker or an online trading platform.
📊 Stock Investment Checklist (100 Points)
Astal Laboratories Ltd • Updated: 2025-09-17 06:20:29
  • 8
    Business
    High
    The pharmaceutical sector is growing, but competition is intense.
  • 10
    Growth
    High
    Revenue growth has been inconsistent over the past few years.
  • 10
    Profitability
    High
    ROE and ROCE are decent, but cash flow is volatile.
  • 9
    Valuation
    High
    Valuation metrics are slightly above industry average.
  • 7
    Balance
    High
    Moderate debt levels, but liquidity is a concern.
  • 6
    Governance
    Good
    Promoter holding is good, but some pledging exists.
  • 5
    Drivers
    Good
    Limited growth drivers identified, execution risks are high.
  • 1
    Technicals
    Low
    Weak market sentiment and low liquidity.
Final Score & Verdict
Score 48 / 100 • Risky
Astal Laboratories Ltd shows potential but faces significant risks and challenges in growth and profitability.

AI Confidence Score

Instead of just “overall score,” broken into categories:

  • Business Strength: 75/100
  • Growth Potential: 70/100
  • Profitability: 65/100
  • Governance: 80/100
  • Market Confidence: 72/100


More Like This

Latest News

More ↗

News items are fetched from Google News RSS; links go to external publishers.